Evidence map›Paper›PMID 31864411›Full record

Observational studyRespiratory research2019

The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study.

Evelyn A Brakema, Aizhamal Tabyshova, Rianne M J J van der Kleij, Talant Sooronbaev, Christos Lionis, Marilena Anastasaki, Pham Le An, Luan Than Nguyen, Bruce Kirenga, Simon Walusimbi and 4 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05934617 (Trajectories of FEV1 After Lung Transplantation), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05934617 unknown statusnot on this mapstarted 2020, after this paper: background citation

Trajectories of FEV1 After Lung Transplantation: Determinants and Clinical Outcomes

TypeobservationalSponsorParis Translational Research Center for Organ TransplantationRan2020 to 2024Enrolled2,500ConditionsLung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Asthma in the intensive care unit: A review of patient characteristics and outcomes.African journal of thoracic and critical care medicine · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Microbiological, Health and Comfort Aspects of Indoor Air Quality in a Romanian Historical Wooden Church.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 5 countries.

Evelyn A BrakemaDepartment of Public Health and Primary Care, Leiden University Medical Center, Postzone V0-P, Postbus 9600, 2300 RC, Leiden, The Netherlands. evelynbrakema@gmail.com.ORCID http://orcid.org/0000-0002-7376-4648
Aizhamal TabyshovaPulmonary Department, National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan.
Rianne M J J van der KleijDepartment of Public Health and Primary Care, Leiden University Medical Center, Postzone V0-P, Postbus 9600, 2300 RC, Leiden, The Netherlands.
Talant SooronbaevPulmonary Department, National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan.
Christos LionisClinic of Social and Family Medicine, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Marilena AnastasakiClinic of Social and Family Medicine, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Pham Le AnUniversity of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
Luan Than NguyenUniversity of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
Bruce KirengaDepartment of Medicine and Makerere Lung Institute, Makerere University, Kampala, Uganda.
Simon WalusimbiDepartment of Medicine and Makerere Lung Institute, Makerere University, Kampala, Uganda.
Maarten J PostmaUnit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Niels H ChavannesDepartment of Public Health and Primary Care, Leiden University Medical Center, Postzone V0-P, Postbus 9600, 2300 RC, Leiden, The Netherlands.
Job F M van BovenDepartment of General Practice & Elderly Care Medicine, University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.
FRESH AIR collaborators
University Medical Center Groningen · NLLeiden University Medical Center · NLUniversity of Crete · GRUniversity of Medicine and Pharmacy at Ho Chi Minh City · VNMakerere University · UG

Funding

Horizon 2020 680997
6 · The paper itself

Abstract

backgroundLow-resource settings are disproportionally burdened by chronic lung disease due to early childhood disadvantages and indoor/outdoor air pollution. However, data on the socioeconomic impact of respiratory diseases in these settings are largely lacking. Therefore, we aimed to estimate the chronic lung disease-related socioeconomic burden in diverse low-resource settings across the globe. To inform governmental and health policy, we focused on work productivity and activity impairment and its modifiable clinical and environmental risk factors.

methodsWe performed a cross-sectional, observational FRESH AIR study in Uganda, Vietnam, Kyrgyzstan, and Greece. We assessed the chronic lung disease-related socioeconomic burden using validated questionnaires among spirometry-diagnosed COPD and/or asthma patients (total N = 1040). Predictors for a higher burden were studied using multivariable linear regression models including demographics (e.g. age, gender), health parameters (breathlessness, comorbidities), and risk factors for chronic lung disease (smoking, solid fuel use). We applied identical models per country, which we subsequently meta-analyzed.

resultsEmployed patients reported a median [IQR] overall work impairment due to chronic lung disease of 30% [1.8-51.7] and decreased productivity (presenteeism) of 20.0% [0.0-40.0]. Remarkably, work time missed (absenteeism) was 0.0% [0.0-16.7]. The total population reported 40.0% [20.0-60.0] impairment in daily activities. Breathlessness severity (MRC-scale) (B = 8.92, 95%CI = 7.47-10.36), smoking (B = 5.97, 95%CI = 1.73-10.22), and solid fuel use (B = 3.94, 95%CI = 0.56-7.31) were potentially modifiable risk factors for impairment.

conclusionsIn low-resource settings, chronic lung disease-related absenteeism is relatively low compared to the substantial presenteeism and activity impairment. Possibly, given the lack of social security systems, relatively few people take days off work at the expense of decreased productivity. Breathlessness (MRC-score), smoking, and solid fuel use are potentially modifiable predictors for higher impairment. Results warrant increased awareness, preventive actions and clinical management of lung diseases in low-resource settings from health policymakers and healthcare workers.

Indexed as

Cost of IllnessSocial ClassAdultAgedChronic DiseaseCross-Sectional StudiesFemaleGlobal HealthGreeceHealth ResourcesHumansKyrgyzstanLung DiseasesMaleMiddle AgedPovertyChronic lung diseaseChronic respiratory diseaseHealth economicsHousehold air pollutionLow-income populationLow-resource countriesObstructive lung diseaseWorkWPAI

Identifiers

PMID31864411
PMCPMC6925865
OpenAlexW2995148346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.